PK
Peter Keen
Independent Investment Committee member at British Patient Capital (Direct Investments)
Greater Cambridge Area
Overview
Peter Keen is an Independent Investment Committee member at British Patient Capital, focusing on direct investments in sectors like BioTech and FinTech. With a background in venture capital and a track record of successful investments in companies like SupaPass and Small Pharma, he brings expertise in due diligence and strategic decision-making to his role.
Having held significant positions like CEO/Executive Director at Cambridge Innovation Capital and Senior Independent Director at Abcam PLC, Peter Keen has a strong history of leadership in the biotechnology and life sciences industries, making valuable contributions to companies through his roles as a Non Executive Director and Board member in various organizations.
Work Experience
Independent Investment Committee member
2021 - Current
Non Executive Director
2017 - 2024
Board of Trustees
2013 - 2021
Chairman of Investment Management Committee, member of Audit Committee
Non Executive Director
2017 - 2019
Non Executive Director
1997 - 2017
Chairman of Audit and Management Engagement Committee
Non Executive Director
2014 - 2016
CEO/Executive Director
2013 - 2016
Senior Independent Director
2005 - 2014
Member of Supervisory Board
2012 - 2013
Non Executive Director
2011 - 2013
Education
BSc (Econ)
1975 - 1978